ConductScience.org, home

Paper33476708

Furin is not required for processing of mesothelin precursor protein.

Joseph S and 3 others. Biochim Biophys Acta Mol Cell Res, 2021. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Furin is not required for processing of mesothelin precursor protein. Papers, record 33476708. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33476708

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Furin is not required for processing of mesothelin precursor protein.
PubMed
Journal
Biochim Biophys Acta Mol Cell Res
PubMed
Year
2021
PubMed
Publication types
Letter, Research Support, N.I.H., Intramural
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.41
iCite
Revised in PubMed
2026-08-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Joseph SSarah
2Zhang XXianyu
3Smith LKLauren K
4Alewine CChristine

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
FurinMajor topic
GPI-Linked ProteinsMajor topic
MutationMajor topic
NeoplasmsMajor topic
Binding Sites
Cell Line, Tumor
Cloning, Molecular
Humans
Mesothelin
Protein Binding

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
ZIA BC011652Intramural NIH HHSUnited StatesZIABC011652PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References10

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131676721Mesothelin Enhances Tumor Vascularity in Newly Forming Pancreatic Peritoneal Metastases.Mol Cancer Res2020https://conductscience.org/library/papers/31676721PubMed
222351743Mesothelin-targeted agents in clinical trials and in preclinical development.Mol Cancer Ther2012https://conductscience.org/library/papers/22351743PubMed
327863199Mesothelin Immunotherapy for Cancer: Ready for Prime Time?J Clin Oncol2016https://conductscience.org/library/papers/27863199PubMed
47690548A mutation of furin causes the lack of precursor-processing activity in human colon carcinoma LoVo cells.Biochem Biophys Res Commun1993https://conductscience.org/library/papers/7690548PubMed
526503962Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors.Cancer Discov2016https://conductscience.org/library/papers/26503962PubMed
630370397Megakaryocyte Potentiating Factor as a Predictive Biomarker for Therapies Against Malignant Mesothelioma.JCO Precis Oncol2018https://conductscience.org/library/papers/30370397PubMed
731463062Mesothelin as a biomarker for targeted therapy.Biomark Res2019https://conductscience.org/library/papers/31463062PubMed
81905715Arg-X-Lys/Arg-Arg motif as a signal for precursor cleavage catalyzed by furin within the constitutive secretory pathway.J Biol Chem1991https://conductscience.org/library/papers/1905715PubMed
98552591Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers.Proc Natl Acad Sci U S A1996https://conductscience.org/library/papers/8552591PubMed
108150545Molecular cloning and expression of a cDNA encoding a protein detected by the K1 antibody from an ovarian carcinoma (OVCAR-3) cell line.Int J Cancer1994https://conductscience.org/library/papers/8150545PubMed

Download CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
42591971Conformational epitope engagement by anti-MSLN ADC RC88 confers resistance to soluble mesothelin.Antib Ther2026https://conductscience.org/library/papers/42591971PubMed
41994562Mesothelin biology and the evolving landscape of targeted immunotherapy.Mol Ther Oncol2026https://conductscience.org/library/papers/41994562PubMed
41335396Decoding the role of mesothelin in tumor dynamics and targeted treatment innovations.Mol Biomed2025https://conductscience.org/library/papers/41335396PubMed
40227616Mesothelin as a Signal Pathways and Epigenetic Target in Cancer Therapy.Cancers (Basel)2025https://conductscience.org/library/papers/40227616PubMed
35523008Low serum mesothelin in pancreatic cancer patients results from retention of shed mesothelin in the tumor microenvironment.Transl Oncol2022https://conductscience.org/library/papers/35523008PubMed
35326701Mesothelin: An Immunotherapeutic Target beyond Solid Tumors.Cancers (Basel)2022https://conductscience.org/library/papers/35326701PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
FURIN5045PubTator's text mininghttps://conductscience.org/library/genes/5045NCBI Gene
MSLN10232PubTator's text mininghttps://conductscience.org/library/genes/10232NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33476708

GET https://conductscience.org/api/papers/v1/33476708/authors